 "Lebanon inks final deal for 2.1 million doses of Pfizer-BioNTech vaccine")
BEIRUT (Reuters) - Lebanon's caretaker health minister signed a final deal on Sunday to secure 2.1 million doses of Pfizer-BioNTech's COVID-19 vaccine as the country battles a steep rise in infections.
The vaccines are expected to arrive in batches starting February, the ministry said in a statement.
The ministry is also cooperating with the private sector to secure 2 million vaccine doses from Astrazenca and Sinopharm, it added.
Lebanon is under a three-week lockdown that ends on Feb. 1 and a strict 24-hour curfew until Jan. 25 after lax measures over the Christmas and New Year's holiday period led to a spike in cases.
In addition to these deals, Lebanon has also signed up for 2.7 million doses to be delivered through COVAX, the global scheme backed by the World Health Organization to provide vaccines to poorer countries.
(Reporting By Maha El Dahan; Editing by Toby Chopra)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app